Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
- Submitting institution
-
University of Newcastle upon Tyne
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 223044-63940-1267
- Type
- D - Journal article
- DOI
-
10.1016/S2215-0366(15)00436-8
- Title of journal
- The Lancet Psychiatry
- Article number
- -
- First page
- 117
- Volume
- 3
- Issue
- 2
- ISSN
- 2215-0374
- Open access status
- Compliant
- Month of publication
- December
- Year of publication
- 2015
- URL
-
http://dx.doi.org/10.1016/S2215-0366(15)00436-8
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
18
- Research group(s)
-
B - Primary Care
- Citation count
- 20
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- a. The author made a substantial contribution either to the conception or design of the study b. The author helped draft the output
- Non-English
- No
- English abstract
- -
